Excision BioTherapeutics Appoints Industry Veteran Lisa Danzig, M.D., as Chief Medical Officer

Share on twitter Share on linkedin SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced the appointment of Lisa Danzig, M.D., as Chief Medical Officer. “Dr. Danzig’s broad infectious disease and drug development experience will play a critical role as […]